These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 20399428)

  • 1. Mild renal dysfunction as a non-traditional cardiovascular risk factor?-Association of cystatin C-based glomerular filtration rate with flow-mediated vasodilation.
    Reffelmann T; Krebs A; Ittermann T; Empen K; Hummel A; Dörr M; Völzke H; Felix SB
    Atherosclerosis; 2010 Aug; 211(2):660-6. PubMed ID: 20399428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between glomerular filtration rate and endothelial function in an elderly community cohort.
    Nerpin E; Ingelsson E; Risérus U; Helmersson-Karlqvist J; Sundström J; Jobs E; Larsson A; Lind L; Ärnlöv J
    Atherosclerosis; 2012 Sep; 224(1):242-6. PubMed ID: 22841608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inverse association of estimated cystatin C- and creatinine-based glomerular filtration rate with left ventricular mass: Results from the Study of Health in Pomerania.
    Aumann N; Baumeister SE; Werner A; Wallaschofski H; Hannemann A; Nauck M; Rettig R; Felix SB; Dörr M; Völzke H; Lieb W; Stracke S
    Int J Cardiol; 2013 Sep; 167(6):2786-91. PubMed ID: 22884092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Is there a relationship between cystatin C and inflammatory status, oxidative stress and other cardiovascular risk factors in non-diabetic patients with chronic kidney disease?].
    Font R; Prats M; Gutiérrez C; Bardají A; Lalana M; Marsillach J; Camps J; Martínez Vea A
    Nefrologia; 2009; 29(3):228-35. PubMed ID: 19554056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homocysteine or renal impairment: which is the real cardiovascular risk factor?
    Potter K; Hankey GJ; Green DJ; Eikelboom JW; Arnolda LF
    Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1158-64. PubMed ID: 18356552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cystatin C identifies cardiovascular risk better than creatinine-based estimates of glomerular filtration in middle-aged individuals without a history of cardiovascular disease.
    Svensson-Färbom P; Ohlson Andersson M; Almgren P; Hedblad B; Engström G; Persson M; Christensson A; Melander O
    J Intern Med; 2014 May; 275(5):506-21. PubMed ID: 24279862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Definition of kidney dysfunction as a cardiovascular risk factor: use of urinary albumin excretion and estimated glomerular filtration rate.
    Cirillo M; Lanti MP; Menotti A; Laurenzi M; Mancini M; Zanchetti A; De Santo NG
    Arch Intern Med; 2008 Mar; 168(6):617-24. PubMed ID: 18362254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cystatin C as a marker of early renal insufficiency in children with congenital neuropathic bladder.
    Fox JA; Dudley AG; Bates C; Cannon GM
    J Urol; 2014 May; 191(5 Suppl):1602-7. PubMed ID: 24679869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cystatin C and cardiovascular risk].
    Taglieri N; Koenig W; Kaski JC
    Ann Biol Clin (Paris); 2010; 68(5):517-29. PubMed ID: 20870574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated serum cystatin C is an independent predictor of cardiovascular events in people with relatively normal renal function.
    Meng L; Yang Y; Qi LT; Wang XJ; Xu GB; Zhang BW
    J Nephrol; 2012; 25(3):426-30. PubMed ID: 21928225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum cystatin C and microalbuminuria in the detection of vascular and renal damage in early stages.
    López Gómez JM; Sacristán Enciso B; Micó M; Arias Meneses F; de Sande Medel F; Alejo S
    Nefrologia; 2011; 31(5):560-6. PubMed ID: 21959722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between serum magnesium levels and cardiovascular events in chronic kidney disease patients.
    Kanbay M; Yilmaz MI; Apetrii M; Saglam M; Yaman H; Unal HU; Gok M; Caglar K; Oguz Y; Yenicesu M; Cetinkaya H; Eyileten T; Acikel C; Vural A; Covic A
    Am J Nephrol; 2012; 36(3):228-37. PubMed ID: 22948239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of serum cystatin C with pulse wave velocity, but not pressure wave reflection, in subjects with normal renal function or mild chronic kidney disease.
    Odaira M; Tomiyama H; Matsumoto C; Yamada J; Yoshida M; Shiina K; Nagata M; Yamashina A
    Am J Hypertens; 2010 Sep; 23(9):967-73. PubMed ID: 20489688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum cystatin C is associated with early stage coronary atherosclerotic plaque morphology on multidetector computed tomography.
    Imai A; Komatsu S; Ohara T; Kamata T; Yoshida J; Miyaji K; Shimizu Y; Takewa M; Hirayama A; Deshpande GA; Takahashi O; Kodama K
    Atherosclerosis; 2011 Oct; 218(2):350-5. PubMed ID: 21782177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive power of serum cystatin C to detect acute kidney injury and pediatric-modified RIFLE class in children undergoing cardiac surgery.
    Hassinger AB; Backer CL; Lane JC; Haymond S; Wang D; Wald EL
    Pediatr Crit Care Med; 2012 Jul; 13(4):435-40. PubMed ID: 22596066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The combined contribution of albuminuria and glomerular filtration rate to the prediction of cardiovascular mortality in elderly men.
    Nerpin E; Ingelsson E; Risérus U; Sundström J; Larsson A; Jobs E; Jobs M; Hallan S; Zethelius B; Berglund L; Basu S; Arnlöv J
    Nephrol Dial Transplant; 2011 Sep; 26(9):2820-7. PubMed ID: 21335440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating levels of osteopontin are closely related to glomerular filtration rate and cardiovascular risk markers in patients with chronic kidney disease.
    Lorenzen J; Krämer R; Kliem V; Bode-Boeger SM; Veldink H; Haller H; Fliser D; Kielstein JT
    Eur J Clin Invest; 2010 Apr; 40(4):294-300. PubMed ID: 20486990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kidney function and cardiovascular disease in the hypertensive population: the ERIC-HTA study.
    Redón J; Cea-Calvo L; Lozano JV; Fernández-Pérez C; Navarro J; Bonet A; González-Esteban J;
    J Hypertens; 2006 Apr; 24(4):663-9. PubMed ID: 16531794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-sensitive troponin T and N-terminal pro-B type natriuretic peptide are associated with cardiovascular events despite the cross-sectional association with albuminuria and glomerular filtration rate.
    Scheven L; de Jong PE; Hillege HL; Lambers Heerspink HJ; van Pelt LJ; Kootstra JE; Bakker SJ; Gansevoort RT;
    Eur Heart J; 2012 Sep; 33(18):2272-81. PubMed ID: 22740385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum adiponectin and cardiovascular risk in chronic kidney disease and kidney transplantation.
    Chitalia N; Raja RB; Bhandara T; Agrawal P; Kaski JC; Jha V; Banerjee D
    J Nephrol; 2010; 23(1):77-84. PubMed ID: 20091490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.